Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4 (Omicron)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4 (Omicron)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4 (Omicron)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4 (Omicron)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.5.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.5.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HD.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HD.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HD.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HD.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HQ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HQ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FD.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FD.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FD.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FD.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used